Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
IDEAYA Biosciences is a precision medicine biotechnology company focused on oncology. The company develops targeted cancer therapies using innovative small molecules. As a clinical-stage biotechnology company, IDEAYA is dedicated to discovering novel medicines to improve treatment outcomes for cancer patients.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
IDEAYA Biosciences is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
IDEAYA Biosciences last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -1.22 USD.
Across its last 3 earnings reports, IDEAYA Biosciences stock moved by ±1.6% on average the following day. The largest reaction was -2.8% on 11/04/2025; 1 of 3 reactions were positive.
IDEAYA Biosciences has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.